ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — MacroGenics Inc. (MGNX) on Thursday reported a loss of $52.2 million in its first quarter.

The Rockville, Maryland-based company said it had a loss of 84 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.

The biopharmaceutical company posted revenue of $9.1 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $13.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX